Epigenetic mechanisms underlying metabolic-inflammatory diseases - Eckardt Treuter
The research of Eckardt Treuter's group attempts to better understand how the epigenome controls metabolic and inflammatory pathways in the context of obesity, type 2 diabetes, fatty liver disease and atherosclerosis. Epigenetic alterations that trigger changes in epigenome activity and gene expression are fundamental reprogramming events that contribute to the development of these diseases.
Epigenetic control of metabolism and inflammation by corepressors
Epigenetic alterations that trigger changes in epigenome activity and gene expression are associated with the development of these diseases. However, the underlying regulatory mechanisms, the critical components involved, and the causal relationship of these associations are currently poorly defined. We address these issues with an emphasis on coregulators, proteins that modify chromatin and cooperate with transcription factors.
Here you can find some of our selected publications.
10th Spetses Summer School on ‘Epigenomics, Nuclear Receptors and Disease’
Our 10th Spetses Summer School on ‘Epigenomics, Nuclear Receptors and Disease’ (FEBS ALC23-001) will take place August 27 - September 1, 2023 at the Island of Spetses in Greece. We welcome applications from PhD students and postdocs who would like to learn more about these research fields by interacting with world-leading experts and peers over 4 intense meeting days.
Application deadline: May 9, 2023